Modus Therapeutics Holding AB

Malaria is not just a serious disease on its own – in some cases, it can also lead to sepsis, a life-threatening condition where the body overreacts to the infection. On #WorldSepsisDay, we want to highlight the connection between malaria and sepsis, and the importance of rapid diagnosis and treatment to save lives. Through research and innovation in biotechnology, we can help combat both malaria and sepsis. #MalariaAwareness #SepsisAwareness #FightSepsis #BiotechForGood

Today, on #WorldSepsisDay, we want to raise awareness about one of the world’s most critical health challenges – sepsis. Every year, more than 49 million people are affected by sepsis, and nearly 11 million lose their lives as a result. Sepsis is a life-threatening condition where the body’s response to an infection damages its own tissues and organs. At Modus, we strive to develop solutions and more effective treatments, which can be crucial in saving lives. Together, we can work to reduce deaths and improve treatment options for patients affected by sepsis. #WorldSepsisDay#September13#FightSepsis #BiotechForLife #SepsisAwareness

Today, on #WorldSepsisDay, we want to raise awareness about one of the world’s most critical health challenges – sepsis. Every year, more than 49 million people are affected by sepsis, and nearly 11 million lose their lives as a result. Sepsis is a life-threatening condition where the body’s response to an infection damages its own tissues and organs. At Modus, we strive to develop solutions and more effective treatments, which can be crucial in saving lives. Together, we can work to reduce deaths and improve treatment options for patients affected by sepsis. #WorldSepsisDay#September13#FightSepsis #BiotechForLife #SepsisAwareness

John Öhd, VD för Modus Therapeutics, deltog igår på Carnegies Småbolagsdag. Denna och övriga presentationer hittar du på vår hemsida under investerare och presentationer. https://lnkd.in/d3jTXasE Läs den fullständiga analysen av Carnegie Investment bank här:

CEO John Öhd to present at Carnegies-småbolagsdag on August 29 at 14:05.   The presentation will be live-streamed via the following link: https://lnkd.in/dXaDQwtZ

Futurebolaget Modus Therapeutics Holding AB: Förväntad studiestart inom räckhåll. Läs den fullständiga analysen här: https://lnkd.in/dWVSGMef $MODTX

Modus Therapeutics - Rapportkommentar Q2 2024 Modus vd John Öhd kommenterar rapporten för det andra kvartalet 2024. Frågor kan ställas direkt i chatten.

Modus Therapetuics - Rapportkommentar Q2 2024 Modus vd John Öhd kommenterar rapporten för det andra kvartalet 2024. Frågor kan ställas direkt i chatten.